PCM
ZURAW

Prelude Capital Management’s Zura Bio Limited Warrants ZURAW Stock Holding History

Prelude Capital Management’s Portfolio ZURAW Stock Details ZURAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-75,000
Closed -$11.3K – 1539
2022
Q4 		$11.3K Sell
75,000
-500
-0.7% -$49 ﹤0.01% 1195
2022
Q3 		$12K Hold
75,500
– – ﹤0.01% 1306
2022
Q2 		$14K Hold
75,500
– – ﹤0.01% 1552
2022
Q1 		$32K Hold
75,500
– – ﹤0.01% 1516
2021
Q4 		$35K Buy
+75,500
New +$40.7K ﹤0.01% 1805

Other funds holding ZURAW

AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return

Prelude Capital Management's ZURAW Position: Q1 2023 in Review

Prelude Capital Management sold out of Zura Bio Limited Warrants (ZURAW) in Q1 2023, closing a stake of 75,000 shares — an estimated $11.3K sold.

Prelude Capital Management first reported a position in ZURAW in Q4 2021 and held it in 5 quarters. The position peaked at $35K in Q4 2021. 16 funds tracked by Wall St. Rank hold ZURAW as of Q1 2023.

  • Prelude Capital Management reported no remaining Zura Bio Limited Warrants position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 75,000 Zura Bio Limited Warrants shares in Q1 2023, an estimated $11.3K.
  • Prelude Capital Management first reported a position in Zura Bio Limited Warrants in Q4 2021 and held it in 5 quarters.
  • Prelude Capital Management's Zura Bio Limited Warrants position peaked at $35K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.